Evidence map›Paper›PMID 34188082›Full record

ArticleScientific reports2021

The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs.

Agnieszka Smolinska, David S Jessop, Kirk L Pappan, Alexandra De Saedeleer, Amerjit Kang, Alexandra L Martin, Max Allsworth, Charlotte Tyson, Martine P Bos, Matt Clancy and 23 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Exhaled SARS-CoV-2 RNA viral load kinetics measured by facemask sampling associates with household transmission.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Article
  7. Observational
  8. Article
  9. Recent advances in facemask devices forTrends in analytical chemistry : TRAC · 2022
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

33 authors at 10 institutions in 4 countries.

Agnieszka Smolinska *Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
David S Jessop *Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
Kirk L Pappan *Owlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
Alexandra De SaedeleerOwlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
Amerjit KangOwlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
Alexandra L MartinOwlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
Max AllsworthOwlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
Charlotte TysonOwlstone Medical Ltd., Cambridge, Cambridgeshire, UK.
Martine P BosinBiome B.V., Amsterdam, The Netherlands.
Matt ClancyinBiome B.V., Amsterdam, The Netherlands.
Mike MorelCambridge Clinical Laboratories Ltd., Cambridge, Cambridgeshire, UK.
Tony CookeCambridge Clinical Laboratories Ltd., Cambridge, Cambridgeshire, UK.
Tom DymondCambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.
Claire HarrisDepartment of Medicine, Addenbrooke's Hospital, Cambridge, UK.
Jacqui GallowayCambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge, UK.
Paul BresserPulmonology, OLVG, Amsterdam, The Netherlands.
Nynke DijkstraPulmonology, OLVG, Amsterdam, The Netherlands.
Viresh JagesarPulmonology, OLVG, Amsterdam, The Netherlands.
Paul H M SavelkoulDepartment of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.
Erik V H BeukenDepartment of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.
Wesley H V NixDepartment of Medical Microbiology, Maastricht University Medical Center, Care and Public Health Research Institute (Caphri), Maastricht, The Netherlands.
Renaud LouisRepiratory Department, CHU Liège, Liège, Belgium.
Muriel DelvauxRepiratory Department, CHU Liège, Liège, Belgium.
Doriane CalmesRepiratory Department, CHU Liège, Liège, Belgium.
Benoit ErnstRepiratory Department, CHU Liège, Liège, Belgium.
Simona PolliniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Anna PeiredDepartment of Experimental and Clinical Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
Julien GuiotRepiratory Department, CHU Liège, Liège, Belgium.
Sara TomassettiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Andries E BuddinginBiome B.V., Amsterdam, The Netherlands.
Frank McCaughanDepartment of Medicine, Addenbrooke's Hospital, Cambridge, UK.
Stefan J MarciniakDepartment of Medicine, Addenbrooke's Hospital, Cambridge, UK.
Marc P van der ScheeOwlstone Medical Ltd., Cambridge, Cambridgeshire, UK. marc.vanderschee@owlstone.co.uk.
Owlstone Medical (United Kingdom) · GBAddenbrooke's Hospital · GBMaastricht University · NLOLVG · NLUniversity of Florence · ITUniversity of Liège · BECambridge Consultants (United Kingdom) · GBCentre Hospitalier Universitaire de Liège · BECambridge University Hospitals NHS Foundation Trust · GBUniversity of Cambridge · GB

Funding

Innovative Medicines Initiative 101005122Medical Research Council G1002610Medical Research Council MR/R009120/1Medical Research Council MR/V028669/1
6 · The paper itself

Abstract

Face masks and personal respirators are used to curb the transmission of SARS-CoV-2 in respiratory droplets; filters embedded in some personal protective equipment could be used as a non-invasive sample source for applications, including at-home testing, but information is needed about whether filters are suited to capture viral particles for SARS-CoV-2 detection. In this study, we generated inactivated virus-laden aerosols of 0.3-2 microns in diameter (0.9 µm mean diameter by mass) and dispersed the aerosolized viral particles onto electrostatic face mask filters. The limit of detection for inactivated coronaviruses SARS-CoV-2 and HCoV-NL63 extracted from filters was between 10 to 100 copies/filter for both viruses. Testing for SARS-CoV-2, using face mask filters and nasopharyngeal swabs collected from hospitalized COVID-19-patients, showed that filter samples offered reduced sensitivity (8.5% compared to nasopharyngeal swabs). The low concordance of SARS-CoV-2 detection between filters and nasopharyngeal swabs indicated that number of viral particles collected on the face mask filter was below the limit of detection for all patients but those with the highest viral loads. This indicated face masks are unsuitable to replace diagnostic nasopharyngeal swabs in COVID-19 diagnosis. The ability to detect nucleic acids on face mask filters may, however, find other uses worth future investigation.

Indexed as

AdultAerosolsAgedCOVID-19FemaleHospitalizationHumansLimit of DetectionMaleMasksMiddle AgedNasopharynxParticle SizeReal-Time Polymerase Chain ReactionRNA, ViralSARS-CoV-2AerosolsRNA, Viral

Identifiers

PMID34188082
PMCPMC8242000
OpenAlexW3176694760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.